MedPath

TEPEZZA

TEPEZZA

Approved
DIN Number

02557061

Drug Class

Human

Market Date

N/A

Company
HC

Amgen Canada Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02557061
AIG Number0166786001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
L04AG13 TEPROTUMUMAB
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification52:08.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

TEPROTUMUMABActive
Strength: 500 MG / VIAL
Monograph: TEPROTUMUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.